A detailed history of Lido Advisors, LLC transactions in Haleon PLC stock. As of the latest transaction made, Lido Advisors, LLC holds 50,891 shares of HLN stock, worth $516,543. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,891
Previous 40,874 24.51%
Holding current value
$516,543
Previous $432,000 12.5%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$9.23 - $10.71 $92,456 - $107,282
10,017 Added 24.51%
50,891 $486,000
Q3 2024

Nov 14, 2024

BUY
$8.32 - $10.7 $82,442 - $106,026
9,909 Added 32.0%
40,874 $432,000
Q2 2024

Aug 14, 2024

BUY
$8.01 - $8.64 $152,326 - $164,306
19,017 Added 159.16%
30,965 $255,000
Q1 2024

May 15, 2024

BUY
$8.02 - $8.67 $95,822 - $103,589
11,948 New
11,948 $101,000
Q3 2022

Nov 14, 2022

BUY
$5.63 - $7.5 $65,003 - $86,595
11,546 New
11,546 $70,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $46.9B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.